A detailed history of Brown Brothers Harriman & CO transactions in Elevance Health, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 653 shares of ELV stock, worth $242,628. This represents 0.0% of its overall portfolio holdings.

Number of Shares
653
Previous 600 8.83%
Holding current value
$242,628
Previous $325,000 4.31%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$500.12 - $562.29 $26,506 - $29,801
53 Added 8.83%
653 $339,000
Q2 2024

Aug 09, 2024

SELL
$497.49 - $547.8 $155,216 - $170,913
-312 Reduced 34.21%
600 $325,000
Q1 2024

May 10, 2024

SELL
$464.61 - $519.96 $68,297 - $76,434
-147 Reduced 13.88%
912 $472,000
Q4 2023

Feb 12, 2024

SELL
$433.51 - $488.06 $297,821 - $335,297
-687 Reduced 39.35%
1,059 $499,000
Q3 2023

Nov 13, 2023

BUY
$414.13 - $475.93 $313,910 - $360,754
758 Added 76.72%
1,746 $760,000
Q2 2023

Aug 07, 2023

BUY
$436.33 - $496.2 $22,252 - $25,306
51 Added 5.44%
988 $438,000
Q1 2023

May 11, 2023

BUY
$446.3 - $502.2 $48,200 - $54,237
108 Added 13.03%
937 $430,000
Q4 2022

Feb 09, 2023

SELL
$465.23 - $546.77 $111,189 - $130,678
-239 Reduced 22.38%
829 $425,000
Q3 2022

Nov 10, 2022

BUY
$445.98 - $507.0 $70,464 - $80,106
158 Added 17.36%
1,068 $485,000
Q2 2022

Aug 11, 2022

BUY
$444.32 - $529.84 $28,436 - $33,909
64 Added 7.57%
910 $439,000
Q1 2022

May 13, 2022

BUY
$428.44 - $502.48 $183,800 - $215,563
429 Added 102.88%
846 $416,000
Q4 2021

Feb 14, 2022

SELL
$370.08 - $467.67 $52,181 - $65,941
-141 Reduced 25.27%
417 $193,000
Q3 2021

Nov 15, 2021

SELL
$357.51 - $398.13 $21,450 - $23,887
-60 Reduced 9.71%
558 $208,000
Q2 2021

Aug 13, 2021

BUY
$352.19 - $401.9 $34,162 - $38,984
97 Added 18.62%
618 $236,000
Q1 2021

May 13, 2021

SELL
$287.7 - $371.31 $75,665 - $97,654
-263 Reduced 33.55%
521 $187,000
Q4 2020

Feb 16, 2021

BUY
$270.17 - $333.15 $64,030 - $78,956
237 Added 43.33%
784 $252,000
Q3 2020

Nov 16, 2020

SELL
$245.73 - $284.63 $163,656 - $189,563
-666 Reduced 54.91%
547 $147,000
Q2 2020

Aug 13, 2020

BUY
$203.3 - $300.59 $93,518 - $138,271
460 Added 61.09%
1,213 $319,000
Q1 2020

May 15, 2020

SELL
$174.68 - $307.74 $42,796 - $75,396
-245 Reduced 24.55%
753 $171,000
Q4 2019

Feb 14, 2020

BUY
$234.82 - $306.42 $20,898 - $27,271
89 Added 9.79%
998 $301,000
Q3 2019

Nov 14, 2019

BUY
$237.69 - $310.48 $187,062 - $244,347
787 Added 645.08%
909 $218,000
Q2 2019

Aug 14, 2019

SELL
$236.25 - $293.76 $4,252 - $5,287
-18 Reduced 12.86%
122 $34,000
Q1 2019

May 15, 2019

BUY
$248.42 - $317.42 $13,911 - $17,775
56 Added 66.67%
140 $40,000
Q4 2018

Feb 14, 2019

BUY
$249.0 - $296.25 $20,916 - $24,885
84 New
84 $22,000
Q1 2018

May 14, 2018

SELL
$215.63 - $258.19 $5,606 - $6,712
-26 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$183.76 - $234.96 $4,777 - $6,108
26
26 $6,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $89.2B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.